MEASUREMENT OF EXCRETION CHARACTERISTICS OF THEOPHYLLINE AND ITS MAJOR METABOLITES

被引：41

作者：

JONKMAN, JH ^{[1
]}

TANG, D ^{[1
]}

UPTON, RA ^{[1
]}

RIEGELMAN, S ^{[1
]}

机构：

[1] UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT PHARM,SAN FRANCISCO,CA 94143

来源：

关键词：

D O I：

10.1007/BF00542096

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：435 / 441

页数：7

共 21 条

[1] CORNISH HH, 1957, J BIOL CHEM, V228, P315
[2] DETERMINATION OF THEOPHYLLINE AND ITS METABOLITES BY LIQUID-CHROMATOGRAPHY
DESIRAJU, RK
SUGITA, ET
MAYOCK, RL
[J]. JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1977, 15 (12) : 563 - 568
[3] GRYGIEL JJ, 1979, CLIN PHARMACOL THER, V26, P660
[4] ABSOLUTE BIOAVAILABILITY OF ORAL THEOPHYLLINE
HENDELES, L
WEINBERGER, M
BIGHLEY, L
[J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (05): : 525 - 527
[5] THEOPHYLLINE TOXICITY DUE TO IMPAIRED THEOPHYLLINE DEGRADATION
JACOBS, MH
SENIOR, RM
[J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1974, 110 (03): : 342 - 345
[6] JENNE JW, 1972, CLIN PHARMACOL THER, V13, P349
[7] KADLEC GJ, 1978, ANN ALLERGY, V41, P337
[8] RENAL CLEARANCE OF THEOPHYLLINE IN MAN
LEVY, G
KOYSOOKO, R
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 16 (07) : 329 - 332
[9] LEVY GL, 1972, CLIN PHARMACOL THER, V13, P258
[10] MITENKO PA, 1973, CLIN PHARMACOL THER, V14, P509